US Stem Cell Inc Reports Legal Appeal Results and Company Direction
SUNRISE, FL / ACCESSWIRE / June 8, 2021 / U.S. Stem Cell, Inc. (OTC:USRM), a corporation that has historically focused...
News
Sparta(TM) Unveils Multi-Layer Virus Protection Program for the Workplace
TORONTO, ON / ACCESSWIRE / June 8, 2021 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital",...
WithHealth to Assist Companies in Response to New York Heroes Act
SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / WithHealth, Inc. (the "Company"), a comprehensive precision concierge care provider,...
Fight’s On: City Trees Endorses UFC Fighter, Sasha Palatnikov, as UFC Loosens Cannabis Restrictions
LAS VEGAS, NV / ACCESSWIRE / June 8, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon...
Optimi Health Announces Product Distribution Agreement with Vitasave
VANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or...
HealthEquity Updates Business Outlook
DRAPER, Utah, June 08, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health...
Delcath Systems Set to Join Russell Microcap® Index
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
TRIOSE Receives Honorable Mention in National Customer Service Association’s All-Stars Awards
Awards Program Honors Trusted Organizations That Consistently Provide Outstanding ServiceWYOMISSING, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- TRIOSE, Inc., the...
Icario Expands Consumer Engagement and Health Action Platform with Acquisition of ChipRewards
Clients can manage full member lifecycle strategies while leveraging Icario Insights and Connect to execute customized engagement initiativesMINNEAPOLIS, June 08,...
Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R),...
Evoke Pharma Announces FDA Orange Book Listing of U.S. Patent for Gimoti®
SOLANA BEACH, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on...
Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chronic Kidney Disease
Webinar Scheduled for Wednesday, June 16th @ 12 pm EDTNEWTON, Mass., June 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:...
ChemoCentryx Announces Abstract on Avacopan in ANCA-Associated Vasculitis Selected as One of the Ten Best Abstracts at the ERA-EDTA Congress
-- Abstract on ‘The Effect of Avacopan, a Complement C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis...
MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan
Availability of EPIFIX Allografts Expected Early 2022 Approval Makes it Possible to Bring EPIFIX’s Healing Properties to as Many as 100,000...
ALR Technologies Announces Formation of an Animal Health Division
Launching the FIRST and ONLY Continuous Glucose Monitor (“CGM”) for Diabetic Companion AnimalsSINGAPORE, June 08, 2021 (GLOBE NEWSWIRE) -- ALR...
Transactions in relation to share buyback program
Pursuant to the authorization granted by the Annual General Meeting of GN Store Nord on March 17, 2021, the Board...
Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress
BION-1301 has been well-tolerated to date in patients with IgAN, with no serious adverse events (SAEs) or treatment discontinuations due...
Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey
Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE)...
Outlook Therapeutics Reports Completion of Patient Dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial
Topline readout of data from NORSE TWO targeted for calendar Q3 2021New Biologics License Application (BLA) filing anticipated in calendar...